Although controlled randomized clinical trials are considered the gold standard to define the efficacy of treatment and are most suitable for finding relevant biomarkers, there is an increasing trend to emphasize and appreciate the opportunities and benefits of data arising from real-world evidence (Di Maio et al. 2020 ; Nazha et al. 2021 ).
← all excerpts
Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.
1
—
—